27th International Conference on Psychiatry & Psychology Health

27th International conference onPsychiatry and psychology health on July 09-10, 2018 at Paris, France

Theme of the conference“Latest Research & Advancement in Psychiatry & Psychology Health”.

Conference brings national and International renowned personalities to a single floor and also provides a good opportunity for business and conference include symposia, workshops, lectures, YRF (Young Research Forum), poster presentation and various other programs for the participant over the globe .

According to (world health organization) WHO, France is the world’s most depressed nation (21%), USA is in 2nd position (19.2%). French consume more anti-depressants than other countries. In France 32% men and 26% women smoke daily.

In France with a population of 65 million ,about 12 million people suffer from one more mental disorder ,where as 83 million people affected worldwide .Rates for women are significantly higher as compared to men

1st Edition of Advancements on Ophthalmology Surgery and Clinical Practice

Upcoming Ophthalmology Conferences | Ophthalmology Conferences | Ophthalmology Conferences 2018 | ophthalmology congress 2018

 

We invite all the participants and attendees from all over the world to attend 1st Edition of Advancements on Ophthalmology Surgery and Clinical Practice during July 31st – August 1st, 2018 at Barcelona, Spain

 

Ophthalmic Surgery 2018 conference will concentrate on latest and exciting innovations in areas of eye surgeries, diagnostics and recent technologies towards eye care. Since the future of ophthalmology lies in research, knowledge and technology and its rapid translation into the clinic to help patients

 

Conference Highlights

 

        Ophthalmology

        Ophthalmic Surgery

        Types of ophthalmic Surgery

        Oculoplasty

        Refractive Eye Surgery

        Common Ophthalmic Disorders

        Pediatric Ophthalmology

        Intraocular melanoma

        Neuro-ophthalmology

        Nano-ophthalmology

        Ophthalmic surgery Practice

        Ophthalmology diagnostic tools

        Benefits of Ophthalmic Surgery

        Surgery in general

        Ocular oncology

        Entrepreneurs Investment Meet

 

We welcome you to go along with us at the Ophthalmology Surgery Conference 2018, where you will make certain to have an important involvement with researchers from around the globe

Celgene Corporation to Webcast

Celgene Corporation to Webcast at Upcoming Investor Conferences

SUMMIT, N.J.–(BUSINESS WIRE)–Celgene Corporation (NASDAQ:CELG) plans to present at four upcoming investor conferences where Celgene management will provide an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the Company’s website at www.celgene.com.

Wednesday, September 6, 2017, Celgene will present at the Baird Global Healthcare Conference in New York City at 3:45 pm ET

Wednesday, September 13, 2017, Celgene will present at the Morgan Stanley Global Healthcare Unplugged Conference in New York City at 9:20 am ET

Thursday, September 14, 2017, Celgene will present at the Bank of America Merrill Lynch Global Healthcare Conference in London at 11:10 am ET

Tuesday, September 26, 2017, Celgene will present at the Cantor Fitzgerald 3rd Annual Healthcare Conference in New York City at 9:45 am ET

About Celgene

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more information, please visit www.celgene.com.

Forward-Looking Statements

This press release contains forward-looking statements, which are generally statements that are not historical facts. Forward-looking statements can be identified by the words “expects,” “anticipates,” “believes,” “intends,” “estimates,” “plans,” “will,” “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates, assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the Securities and Exchange Commission.

Hyperlinks are provided as a convenience and for informational purposes only. Celgene bears no responsibility for the security or content of external websites.

Contacts

Celgene Corporation
Patrick E. Flanigan III, 908-673-9969
Corporate VP, Investor Relations
or
Celgene Corporation
Brian Gill, 908-673-9530
VP, Corporate Communications